StockMarketWire.com - Respiratory diseases treatment developer Verona Pharma said chief medical officer Kenneth Newman had resigned, effective at the end of April, to pursue other opportunities.

The company said it had commenced a search for a replacement.


At 1:42pm: [LON:VRP] Verona Pharma PLC share price was -5p at 170p



Story provided by StockMarketWire.com